A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
Public ClinicalTrials.gov record NCT03361501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-center, Multi-national, Placebo-controlled, Randomized, Double-blind 26 Week Study to Assess the Safety and Efficacy of CaPre® in Patients With Severe Hypertriglyceridemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting TG levels in subjects with fasting TG levels ≥500 mg/dL and ≤1500 mg/dL (≥5.7 mmol/L and ≤17.0 mmol/L) after 12 weeks of treatment. Approximately 615 subjects will be screened to obtain 245 randomized subjects following a treatment allocation ratio of 2.5:1 (CaPre:placebo).
Study identification
- NCT ID
- NCT03361501
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 278 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 1, 2018 (Actual)
- Primary completion
- Sep 24, 2019 (Actual)
- Completion
- Jan 9, 2020 (Actual)
- Last update posted
- Aug 12, 2020
2018 – 2020
United States locations
- U.S. sites
- 53
- U.S. states
- 24
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research site | Birmingham | Alabama | 35216 | — |
| Research site | Childersburg | Alabama | 35044 | — |
| Research site | Encino | California | 91436 | — |
| Research site | Long Beach | California | 90806 | — |
| Research site | San Diego | California | 92111 | — |
| Research site | Thousand Oaks | California | 91360 | — |
| Research site | Torrance | California | 90503 | — |
| Research site | Monument | Colorado | 80132 | — |
| Research site | Clearwater | Florida | 33756 | — |
| Research site | Coral Gables | Florida | 33134 | — |
| Research site | DeLand | Florida | 32720 | — |
| Research site | Fort Lauderdale | Florida | 33308 | — |
| Research site | Jacksonville | Florida | 32205 | — |
| Research site | Jacksonville | Florida | 32277 | — |
| Research site | Miami | Florida | 33133 | — |
| Research site | Miami | Florida | 33134 | — |
| Research site | Miami | Florida | 33144 | — |
| Research site | Miami Lakes | Florida | 33016 | — |
| Research site | Dunwoody | Georgia | 30338 | — |
| Research site | Peachtree Corners | Georgia | 30071 | — |
| Research site | Savannah | Georgia | 31406 | — |
| Research site | Boise | Idaho | 83712 | — |
| Research site | Wauconda | Illinois | 60084 | — |
| Research site | Iowa City | Iowa | 52242 | — |
| Research site | Overland Park | Kansas | 66210 | — |
| Research site | Biddeford | Maine | 04005 | — |
| Research site | Baltimore | Maryland | 21229 | — |
| Research site | Hyattsville | Maryland | 20782 | — |
| Research site | Flint | Michigan | 48503 | — |
| Research site | Tupelo | Mississippi | 38801 | — |
| Research site | Norfolk | Nebraska | 68701 | — |
| Research site | Las Vegas | Nevada | 89120 | — |
| Research site | Las Vegas | Nevada | 89169 | — |
| Research site | Albany | New York | 12206 | — |
| Research site | Laurelton | New York | 11413 | — |
| Research site | New Windsor | New York | 12553 | — |
| Research site | New York | New York | 10036 | — |
| Research site | The Bronx | New York | 10468 | — |
| Research site | Morganton | North Carolina | 28655 | — |
| Research site | Marion | Ohio | 43302 | — |
| Research site | Oklahoma City | Oklahoma | 73112 | — |
| Research site | Lansdale | Pennsylvania | 19446 | — |
| Research site | Gaffney | South Carolina | 29340 | — |
| Research site | Summerville | South Carolina | 29485 | — |
| Research site | Union | South Carolina | 29379 | — |
| Research site | Georgetown | Texas | 78626 | — |
| Research site | Houston | Texas | 77043 | — |
| Research site | Houston | Texas | 77074 | — |
| Research site | Houston | Texas | 77079 | — |
| Research site | Kerrville | Texas | 78028 | — |
| Research site | Clinton | Utah | 84015 | — |
| Research site | Ogden | Utah | 84405 | — |
| Research site | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03361501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03361501 live on ClinicalTrials.gov.